Indaptus Therapeutics, Inc.
INDP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857044
No open-market purchases or sales by Indaptus Therapeutics, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.15M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Indaptus Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +4 vs. Q1 2024
- Shares held
- 599.9K
- +12.1K (+2.1%) vs. Q1 2024
- Total value
- $1.26M
- −$51.8K (−3.9%) vs. Q1 2024
- New holders
- 5
- 4 more added
- Sold out
- 1
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INDP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $1.15M |
| Q1 2026 | 6 | $128.5K |
| Q4 2025 | 4 | $93.7K |
| Q3 2025 | 5 | $57.9K |
| Q2 2025 | 5 | $3.23K |
| Q1 2025 | 19 | $377.8K |
| Q4 2024 | 20 | $539.6K |
| Q3 2024 | 18 | $750.2K |
| Q2 2024 | 21 | $1.26M |
| Q1 2024 | 17 | $1.31M |
| Q4 2023 | 19 | $1.06M |
| Q3 2023 | 16 | $1.57M |
| Q2 2023 | 15 | $1.11M |
| Q1 2023 | 15 | $1.08M |
| Q4 2022 | 18 | $838.5K |
| Q3 2022 | 18 | $1.22M |
| Q2 2022 | 17 | $1.31M |
| Q1 2022 | 17 | $6.81M |
| Q4 2021 | 15 | $10.5M |
| Q3 2021 | 15 | $4.24M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Indaptus Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 256,265 | $543.3K | 0.00% | 00.0% | Unchanged |
| Investment House LLC | 102,437 | $217.2K | 0.01% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 59,309 | $125.8K | 0.00% | +4,542+8.3% | Added |
| Pine Valley Investments Ltd Liability Co | 44,085 | $93.5K | 0.01% | −60−0.1% | Reduced |
| Strategy Asset Managers LLC | 45,336 | $86.6K | 0.02% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 26,600 | $56.4K | 0.00% | +500+1.9% | Added |
| Vivaldi Capital Management, LLC | 24,000 | $50.9K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 22,210 | $47.1K | 0.00% | +22,210 | New |
| State Street Corp | 13,073 | $27.7K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,102 | $8.70K | 0.00% | +36+0.9% | Added |
| Morgan Stanley | 884 | $1.87K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 692 | $1.47K | 0.00% | −1,244−64.3% | Reduced |
| Bangor Savings Bank | 400 | $848 | 0.00% | 00.0% | Unchanged |
| Beaird Harris Wealth Management, LLC | 300 | $636 | 0.00% | +300 | New |
| FMR LLC | 79 | $167 | 0.00% | +79 | New |
| Wells Fargo & Company | 64 | $136 | 0.00% | −41−39.0% | Reduced |
| Bank of America Corp | 42 | $89 | 0.00% | +42 | New |
| JPMorgan Chase & Co | 15 | $32 | 0.00% | +1+7.1% | Added |
| Massmutual Trust Co FSB | 14 | $30 | 0.00% | +14 | New |
| Group One Trading, L.P. | 7 | $15 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 1 | $2 | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,232−100.0% | Sold out |